EP08.01-043 Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced Non-small Cell Lung Cancer (NSCLC)

While recent studies have examined the impact of clinicopathologic features on clinical outcomes to PD-(L)1 monotherapy in NSCLC, factors that influence chemoimmunotherapy efficacy are in need of further investigation.